SEP 16, 2015 04:57 PM PDT

Aggressive AML

University of Manchester scientists have identified a gene, FOXC1, that, if turned on, can cause more aggressive cancer in a fifth of acute myeloid leukemia (AML) patients, according to a Cancer Research UK study published in the journal Cancer Cell and reported in Drug Discovery & Development
Gene can make acute myeloid leukemia more aggressive.
The FOXC1 gene is normally turned on during embryonic development. It is needed to turn cells into specialized tissues, like the eyes, kidney, brain and bone, but this new research found that in certain patients with AML, a type of blood cancer that affects white blood cells and the bone marrow, this gene was wrongly turned on inside the patient’s cancer cells.

When it is turned on in blood cell tissue, FOXC1 stunts the development of blood cells and stops them from maturing into normal specialized blood cells. This condition causes the cancer to be more aggressive, because young cells are able to replicate more than mature cells. This, in turn, causes cancer cells to grow faster and become more difficult to treat.

About 2,900 people were diagnosed with AML in the UK in 2011. Of that number, around 20 per cent would have had the FOXC1 gene wrongly turned on in their cancer.

According to Dr Tim Somervaille, lead author from the Cancer Research UK Manchester Institute at The University of Manchester, “This is an important finding which helps us understand how acute myeloid leukemia develops and why some cases of AML are more aggressive than others. Here, instead of being faulty or mutated, this normal gene is turned on in the wrong place at the wrong time which makes the cancer grow more rapidly. There are certain situations where this gene is necessary, as in the development of the eye and skeleton before birth. But when it’s switched on in the wrong tissue, it causes more aggressive forms of leukemia.” 

Nell Barrie, senior science communication manager at Cancer Research UK, added, “It’s essential that we continue to research basic biology to further understand how cells become cancerous. In this study, identifying a specific gene behind more aggressive forms of acute myeloid leukemia could give clues for new ways to personalize treatments for select patients. The better we understand the nuts and bolts of each cancer, the sooner we can find new ways to stop it.”
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
OCT 21, 2019
Cancer
OCT 21, 2019
Will a Capsule Do Away With Colon Cancer Screening Prep?
While the official colon cancer screening guidelines say people with an average risk for colon cancer should start to get screened starting at age 50, only...
OCT 21, 2019
Cancer
OCT 21, 2019
Understanding TP53's role in cancer
New research published in the journal Cell Reports sheds light on the role of the TP53 gene in preventing the spread of cancer. The TP53 gene codes tumor p...
OCT 21, 2019
Cancer
OCT 21, 2019
Gut fungi linked to pancreatic cancer
In a recent paper published in Nature paper, researchers from the New York University (NYU) School of Medicine in NYC report that gut fungi may be lin...
OCT 21, 2019
Cancer
OCT 21, 2019
Using temperature to awaken immune response to fight brain cancer
Glioblastoma is the most common form of adult brain cancer and also one of the most aggressive human cancers. Immunotherapy has yet to be shown proven effe...
OCT 21, 2019
Cancer
OCT 21, 2019
Not worth the risk: e-cigs and lung inflammation
E-cigarette use is on the rise and according to new research published in the journal Cancer Prevention Research, even short-term usage of e-cigs can be a ...
OCT 21, 2019
Cancer
OCT 21, 2019
Altered DNA methylation controls genes in cancer
New research published in the journal Genome Biology provide new information on genomic structural variation via DNA methylation and its connection to gene...
Loading Comments...